Fangyuan Gao

机构：Capital Medical University, People's Liberation Army 401 Hospital, Beijing Ditan Hospital · ORCID：0000-0002-0064-2105

发表论文 42 篇 · 总被引 821 次 · h-index 13

代表论文

• Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway (2021 · Phytomedicine · 被引 118)
• LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis (2019 · Artificial Cells Nanomedicine and Biotechnology · 被引 87)
• Low‐dose rescue tirofiban in mechanical thrombectomy for acute cerebral large‐artery occlusion (2020 · European Journal of Neurology · 被引 44)
• Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure (2020 · BMC Gastroenterology · 被引 31)
• Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure (2023 · Frontiers in Immunology · 被引 27)
• Nomogram prediction of individual prognosis of patients with acute-on-chronic hepatitis B liver failure (2018 · Digestive and Liver Disease · 被引 25)